Ledger.Open graph →

SEC Form D · filed November 8, 2016

Saptalis Pharmaceuticals, LLC

Offering

$6.5M

Sold

$6.5M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

HAUPPAUGE, NY

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Polireddy Dondeti · Hauppauge, NYExec · Director Tatiana Akimova · Hauppauge, NYExec · Director Venkata T. Gobburu · Cupertino, CAExec · Director Alvin Tamsir · Emeryville, CAExec · Director Matt Ocko · Emeryville, CAExec · Director Blackbear Asset Management Inc · CHICAGO, ILExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗